172 related articles for article (PubMed ID: 10623767)
1. Human immunodeficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cells.
Spiegel HM; Ogg GS; DeFalcon E; Sheehy ME; Monard S; Haslett PA; Gillespie G; Donahoe SM; Pollack H; Borkowsky W; McMichael AJ; Nixon DF
J Virol; 2000 Jan; 74(2):1018-22. PubMed ID: 10623767
[TBL] [Abstract][Full Text] [Related]
2. Progressive loss of IL-2-expandable HIV-1-specific cytotoxic T lymphocytes during asymptomatic HIV infection.
Jin X; Wills M; Sissons JG; Carmichael A
Eur J Immunol; 1998 Nov; 28(11):3564-76. PubMed ID: 9842899
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type 1 replication, immune activation, and circulating cytotoxic T cells against uninfected CD4+ T cells.
Kottilil S; Gamberg J; Bowmer I; Trahey J; Howley C; Gallant M; Grant M
J Clin Immunol; 2000 May; 20(3):175-86. PubMed ID: 10941825
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood cytotoxic gammadelta T lymphocytes from patients with human immunodeficiency virus type 1 infection and AIDS lyse uninfected CD4+ T cells, and their cytocidal potential correlates with viral load.
Sindhu ST; Ahmad R; Morisset R; Ahmad A; Menezes J
J Virol; 2003 Feb; 77(3):1848-55. PubMed ID: 12525619
[TBL] [Abstract][Full Text] [Related]
5. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
[TBL] [Abstract][Full Text] [Related]
6. Maintenance of HIV-specific central and effector memory CD4 and CD8 T cells requires antigen persistence.
Sester U; Sester M; Köhler H; Pees HW; Gärtner BC; Wain-Hobson S; Bocharov G; Meyerhans A
AIDS Res Hum Retroviruses; 2007 Apr; 23(4):549-53. PubMed ID: 17451343
[TBL] [Abstract][Full Text] [Related]
7. CD4(+)CD8(dim) T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens.
Suni MA; Ghanekar SA; Houck DW; Maecker HT; Wormsley SB; Picker LJ; Moss RB; Maino VC
Eur J Immunol; 2001 Aug; 31(8):2512-20. PubMed ID: 11500836
[TBL] [Abstract][Full Text] [Related]
8. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
Lapham C; Golding B; Inman J; Blackburn R; Manischewitz J; Highet P; Golding H
J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
[TBL] [Abstract][Full Text] [Related]
9. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.
Lubaki NM; Shepherd ME; Brookmeyer RS; Hon H; Quinn TC; Kashamuka M; Johnson M; Gottle R; Devers J; Lederman HM; Bollinger RC
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):19-30. PubMed ID: 10534143
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
Carmichael A; Jin X; Sissons P; Borysiewicz L
J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
[TBL] [Abstract][Full Text] [Related]
11. Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects.
Komanduri KV; Donahoe SM; Moretto WJ; Schmidt DK; Gillespie G; Ogg GS; Roederer M; Nixon DF; McCune JM
Virology; 2001 Jan; 279(2):459-70. PubMed ID: 11162802
[TBL] [Abstract][Full Text] [Related]
12. Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T-cell responses from chronically infected individuals.
Engelmayer J; Larsson M; Lee A; Lee M; Cox WI; Steinman RM; Bhardwaj N
J Virol; 2001 Mar; 75(5):2142-53. PubMed ID: 11160718
[TBL] [Abstract][Full Text] [Related]
13. Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection.
Zaunders JJ; Dyer WB; Wang B; Munier ML; Miranda-Saksena M; Newton R; Moore J; Mackay CR; Cooper DA; Saksena NK; Kelleher AD
Blood; 2004 Mar; 103(6):2238-47. PubMed ID: 14645006
[TBL] [Abstract][Full Text] [Related]
14. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
Matloubian M; Concepcion RJ; Ahmed R
J Virol; 1994 Dec; 68(12):8056-63. PubMed ID: 7966595
[TBL] [Abstract][Full Text] [Related]
15. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.
Le Borgne S; Février M; Callebaut C; Lee SP; Rivière Y
J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581
[TBL] [Abstract][Full Text] [Related]
16. Single-cell level response of HIV-specific and cytomegalovirus-specific CD4 T cells correlate with viral control in chronic HIV-1 subtype A infection.
Eller MA; Eller LA; Ratto-Kim S; Ouma BJ; Lo V; de Souza M; Guwatudde D; Nails B; Michael NL; Wabwire-Mangen F; Robb ML; Marovich MA; Sandberg JK; Currier JR
J Acquir Immune Defic Syndr; 2012 Sep; 61(1):9-18. PubMed ID: 22580564
[TBL] [Abstract][Full Text] [Related]
17. Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men.
Rinaldo CR; Beltz LA; Huang XL; Gupta P; Fan Z; Torpey DJ
AIDS Res Hum Retroviruses; 1995 Apr; 11(4):481-9. PubMed ID: 7632463
[TBL] [Abstract][Full Text] [Related]
18. Lysis of CD4+ lymphocytes by non-HLA-restricted cytotoxic T lymphocytes from HIV-infected individuals.
Grant MD; Smaill FM; Rosenthal KL
Clin Exp Immunol; 1993 Sep; 93(3):356-62. PubMed ID: 8103717
[TBL] [Abstract][Full Text] [Related]
19. The role of CD4+ T cell help and CD40 ligand in the in vitro expansion of HIV-1-specific memory cytotoxic CD8+ T cell responses.
Ostrowski MA; Justement SJ; Ehler L; Mizell SB; Lui S; Mican J; Walker BD; Thomas EK; Seder R; Fauci AS
J Immunol; 2000 Dec; 165(11):6133-41. PubMed ID: 11086046
[TBL] [Abstract][Full Text] [Related]
20. Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load.
Tilton JC; Luskin MR; Johnson AJ; Manion M; Hallahan CW; Metcalf JA; McLaughlin M; Davey RT; Connors M
J Virol; 2007 Mar; 81(6):2713-25. PubMed ID: 17182676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
